Condition
Inflammatory Myopathies clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Inflammatory Myopathies clinical trials that are recruiting, at sites in 4 countries (most in Poland (1), Spain (1), China (1)). By phase: Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest Inflammatory Myopathies clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Inspiratory muscle training for people with inflammatory myopathy | — | Warsaw | Recruiting | Dec 10, 2025 |
| Interferon patterns in cancer patients receiving CTLA-4 or PD-1/PD-L1 inhibitors versus autoimmune disease | — | Pamplona, Navarre | Recruiting | Nov 25, 2025 |
| Universal CD19-targeting CAR-γδT cell therapy for refractory autoimmune diseases | Phase 1/2 | Beijing | Recruiting | Feb 14, 2025 |
| Identifying biomarkers in systemic sclerosis and inflammatory myopathies | — | Strasbourg, Bas-Rhin | Recruiting | Jun 8, 2021 |
All recruiting trials (4)
-
Inspiratory muscle training for people with inflammatory myopathy
This project will test whether a 3-month home-based inspiratory muscle training program can strengthen breathing muscles and improve walking distance, fatigue, and quality of life for adults with inflammatory myopathy.
-
Interferon patterns in cancer patients receiving CTLA-4 or PD-1/PD-L1 inhibitors versus autoimmune disease
This project will test whether blood interferon levels can help predict immune-related side effects in adults starting checkpoint inhibitor immunotherapy by comparing them with people who have autoimmune diseases.
-
Universal CD19-targeting CAR-γδT cell therapy for refractory autoimmune diseases
This trial will try infusing universal CD19-targeting CAR-γδT cells into adults with refractory B cell–driven autoimmune diseases to see if removing autoreactive B cells improves symptoms.
-
Identifying biomarkers in systemic sclerosis and inflammatory myopathies
This study is trying to find specific markers in the blood and tissues of people with systemic sclerosis and inflammatory myopathies to better understand their diseases and how they progress over time.
Related topics
Quick answers
How many Inflammatory Myopathies clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Poland (1 trial), Spain (1 trial), China (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.